Used in pharmaceutical research as a potential central nervous system agent, particularly investigated for its sedative and hypnotic properties. It interacts with benzodiazepine receptors, making it a candidate for the development of anxiolytic or sleep-inducing drugs. Its structure supports binding affinity to GABAergic systems, which play a key role in regulating neuronal excitability. Due to its specific receptor activity, it is also studied for structure-activity relationship (SAR) modeling in neuroactive compound design. Not approved for clinical use; primarily serves as a research compound in early-stage drug discovery.